Pricing Log in Create free account

Korro Bio, Inc. (KRRO) vs Molecular Partners AG Sponsored ADR (MOLN)

Korro Bio, Inc. and Molecular Partners AG Sponsored ADR are both Biotechnology companies. Korro Bio, Inc. and Molecular Partners AG Sponsored ADR are of similar size ($143.5M and $137.1M). Molecular Partners AG Sponsored ADR grew revenue faster over the last twelve months: −28.0% against −81.9%. Across the 12 metrics below, Korro Bio, Inc. leads on 6 and Molecular Partners AG Sponsored ADR on 6.

Valuation

Metric KRRO MOLN Biotechnology median
P/E n/m n/m 8.50
P/S 23.51 24.43 9.71
P/B 1.46 1.86 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 8.38 9.21 9.21
Earnings yield (117.23%) (48.03%) (33.15%)
Free cash flow yield (45.42%) (41.59%) (25.50%)

Profitability

Metric KRRO MOLN Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (97.69%) (63.89%) (56.36%)
Return on assets (62.03%) (52.73%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KRRO MOLN Biotechnology median
Revenue growth (TTM) (81.87%) (27.99%) 6.02%
EPS growth (last fiscal year) (33.19%) (9.94%) 30.26%
Revenue growth, 5-year CAGR — (23.12%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KRRO MOLN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.55 7.27 4.72
Net debt to EBITDA 0.64 1.66 0.96

Dividend

Metric KRRO MOLN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KRRO MOLN Biotechnology median
Market cap 137.09m 143.47m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack